Loading video...

Video Failed to Load

Go Home

Five sourced findings raise a basic question: are high drug prices funding discovery, or rewarding the companies best positioned to acquire, market, and extend the life of discoveries made elsewhere? Rob Burgess follows the money behind the innovation defense.

110,800 views • 2 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos